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Abstract
Leishmaniasis is caused by unicellular eukaryotic obligate intracellular protozoa of the genus Leishmania that is
endemic in over 98 countries in the world-most of which are developing countries including Ethiopia. It is transmitted
by phlebotomine sandflies. The eye may be affected in cutaneous, mucocutaneous and Post Kala-Azar Dermal
Leishmaniasis. We report a case of ocular leishmaniasis with eyelid and conjunctival involvement that had simulated
ulcerative blepharoconjunctivitis not responding to conventional antibiotics. The patient was diagnosed by
microscopy of a sample obtained via direct smear from the lesions. He was treated with systemic sodium
stibogluconate (20 mg/kg/day) for 45 days and was clinically cured with this treatment.
Keywords: Ocular leishmaniasis; Chronic Ulcerative
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Case Report
A 29 year-old male patient presented to our center with bilateral
eyelid swelling associated with redness of the eyes, itching sensation,
scant whitish discharge and mild photophobia. He was seen at our
center one month prior for the same complaint and was treated for
chronic ulcerative blepharoconjunctivitis with topical and systemic
antibiotics but did not improve. He lives in a village in northwestern
Ethiopia, in close proximity to the Ethio-Sudan border, where visceral
leishmaniasis (VL) is endemic. Review of his medical history revealed
that he was treated for VL in the nearby hospital with sodium
stibogluconate five times in the past.
Figure 1: Appearance of the eyelids and conjunctiva at presentation.
The first episode occurred six years ago and his recent infection one
year previously had responded well to treatment. He has no
concomitant HIV infection. He claimed to have no ocular involvement
when he was treated for VL. In his latest presentation, his visual acuity
was 6/6 in both eyes. His eyelids were erythematous, edematous,
indurated and ulcerated with decreased density of lashes. He had
bilateral conjunctival inflammation with chemosis (Figure 1). His
cornea was clear and quiet anterior chambers in both eyes. Systemic
examinations revealed mild hepatosplenomegaly but no lesions on the
skin. Given that he is from a VL endemic area and his prior episodes of
VL led to the suspicion of ocular leishmaniasis. Aspirate from the
eyelid swelling was done that revealed a high load (+ 6) of Leishman
Donovan bodies (Figure 2).
Figure 2: Direct Smear was positive for Leishman Donovan bodies
(Giemsa stain).
Based on this result, the patient was referred to the Leishmaniasis
Research and Treatment Center of our hospital where he was treated
with sodium stibogluconate 20mg/kg/day for 45 days with complete
clinical cure (Figure 3).
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Figure 3: Appearance of the patient on completion of treatment.
Discussion
Encompassing a complex group of disorders, leishmaniasis is
caused by a unicellular eukaryotic obligatory intracellular protozoa of
the genus Leishmania that is endemic in over 98 countries in the
world-most of them developing including Ethiopia. The organisms are
transmitted by phlebotomine sandflies of the genus Phlebotomus in
the "Old World" (Asia, Africa, and Europe) and the genus Lutzomyia
in the "New World" (the Americas) [1].
To date, more than 20 species of leishmaniasis have been identified
including L. donovani, L. major, L. tropica, L. aethiopica, L.
braziliensis and they produce widely varying clinical syndromes
ranging from self-healing cutaneous ulcers to fatal visceral disease.
These syndromes fall into three broad categories: visceral
leishmaniasis (VL), cutaneous leishmaniasis (CL), and mucosal
leishmaniasis (ML). The eye may be affected in cutaneous,
mucocutaneous and Post Kala–Azar Dermal Leishmaniasis (PKDL)
[2].
Cutaneous leishmaniasis generally involves eyelids in 2-5% of the
cases, most often on the external corner. The pathologic pattern is
comparable to what can be observed on the rest of the skin but the
fragility of the eyelid gives an increased risk of local spreading. The
eyelid infection may result in eyelid edema, ulceration, and scarring
leading to ectropion, with occasional spread to conjunctiva and
lacrimal ducts. In mucocutaneous leishmaniasis, the lesions are more
destructive and may lead to loss of normal ocular anatomy [3,4].
Further involvement of ocular structures may result in granular or
nodular conjunctivitis, episcleritis, interstitial keratitis, nodular
keratitis with heavy pannus formation, and ulcerative keratitis [5,6]. In
some patients, phlyctenular and nummular keratitis have been
observed, which appears to be because of a hypersensitivity reaction to
the Leishmania antigens [7]. Other ocular manifestations include
anterior uveitis, glaucoma, retinal hemorrhages, central retinal vein
thrombosis, optic neuritis, chronic dacryocystitis, scleromalacia,
epidermoid carcinoma and ptosis [8,9].
Clinical diagnosis of ocular lesions is difficult because it has
nonspecific characteristics and can simulate other conditions like
chalazion, eyelid or conjunctival tumors, dacryocystitis or nonspecific
interstitial keratitis and uveitis [10,11].
Demonstration of amastigotes (Leishman-Donovan bodies) in
material obtained from a lesion remains the diagnostic gold standard.
Microscopic examination of eyelid skin smears, aspirates of eyelid or
conjunctival lesions, or biopsies of the lesion is used for detection of
parasites. Culture of smear or biopsy material may yield leishmania.
PCR is more sensitive than microscopy and culture and allows
identification of leishmania to the species level.
Although lesions in cutaneous leishmaniasis heal spontaneously in
the majority of cases, their potential blinding complications in ocular
involvement indicates that treatment is needed. The most common
medications currently used for treatment of leishmaniasis include
Pentavalent antimonials, amphotericin B, Liposomal Amphotericin B,
Miltefosine and Paromomycin sulfate.
Conclusion
If left untreated, ocular leishmaniasis is a potentially blinding
disease. Delays in diagnosis and treatment, as well as the patient's own
immune reaction to the pathogen can cause irreversible damage to the
eye or its adnexae. Therefore, maintaining a high level of suspicion
amongst physicians who work in endemic areas can lead to early
diagnosis and treatment, hence preventing blinding complications.
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